Market Place
Sourcing Support
Guardant, Nuvalent partner on cancer diagnostics
30 Apr 2026 //
FIRSTWORD PHARMA
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test
16 Mar 2026 //
BUSSINESSWIRE
Guardant Health`s Shield Blood-Based Screening Test
10 Mar 2026 //
BUSSINESSWIRE
Dempsey, Guardant Health to Raise Colorectal Cancer Awareness
03 Mar 2026 //
BUSINESSWIRE
Guardant Picks Patrick Dempsey For Cancer Blood Test Awareness
03 Mar 2026 //
FIERCE PHARMA
Guardant Reveal Backed by Largest Stage III Colon Cancer MRD
02 Feb 2026 //
BUSINESSWIRE
Guardant Health Showcases Multiomic Liquid Biopsy Impact
05 Dec 2025 //
BUSINESSWIRE
Shield CRC Blood Test Shows 95% Adherence In 20K-Patient Study
05 Nov 2025 //
BUSINESSWIRE
Guardant Backs ALA`s Lung Cancer Testing Awareness Drive
25 Sep 2025 //
FIERCE PHARMA
Guardant, Quest Partner To Expand Shield Blood Screening In US
24 Sep 2025 //
BUSINESSWIRE
Guardant, LabFlorida Partner to Offer Shield CRC Test to Seniors
11 Sep 2025 //
BUSINESSWIRE
Guardant, PathGroup Partner to Bring Shield Blood Test
08 Sep 2025 //
BUSINESSWIRE
Guardant and Van Der Beek Promote Colon Cancer Blood Test
30 Jul 2025 //
FIERCE PHARMA
Vanguard Starts Study on Guardant`s Shield Cancer Detection Test
15 Jul 2025 //
BUSINESSWIRE
Guardant Health Wins Fast Company’s 2025 World Changing Ideas Awa
10 Jun 2025 //
BUSINESSWIRE
ESMO Open study shows Guardant Reveal`s performance in detecting
09 Jun 2025 //
BUSINESSWIRE
NCCN Adds Shield Blood Test To Colorectal Cancer Guidelines
02 Jun 2025 //
BUSINESSWIRE
Guardant Reveals MRD study in Colon Cancer for Treatment Decision
31 May 2025 //
BUSINESSWIRE
Guardant Health Introduces Immunohistochemistry Testing for Tumor
21 May 2025 //
BUSINESSWIRE
TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List
08 May 2025 //
BUSINESSWIRE
Guardant Health Launches Guardant360 Tissue for Cancer Profiling
28 Apr 2025 //
BUSINESSWIRE
Guardant & ConcertAI Launch Data-As-A-Service For Therapy R&D
16 Jan 2025 //
BUSINESSWIRE
Guardant To Present Blood Test RWD Studies At ASCO 2024
30 May 2024 //
BUSINESSWIRE
FDA panel gives OK to Guardant`s colorectal cancer blood test
23 May 2024 //
FIERCE BIOTECH
Guardant To Present Shield CRC Screening Blood Test Data
16 May 2024 //
BUSINESSWIRE
Guardant preps for FDA review of colorectal cancer blood test
13 May 2024 //
FIERCE BIOTECH
Guardant Health to Present Data of Epigenomics at 2024 AACR Annual Meeting
03 Apr 2024 //
BUSINESSWIRE
Guardant Announces Tentative Date of Panel Review of Shield Blood Test
19 Dec 2023 //
BUSINESSWIRE
Singapore approves Guardant360 CDx blood testfor patients advanced solid cancers
30 May 2023 //
BIOSPECTRUM ASIA
